Jeffrey S. Hatfield
Director · Vir Biotechnology, Inc.
Individual
- 2026
- May 28, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey S. Hatfield files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Endurance (Cayman) Ltd - $9.98M in VIR purchases and sales in the last 12 months
- Vicki L. Sato - $1.47M in VIR purchases and sales in the last 12 months
- Backer Marianne de - $947K in VIR purchases and sales in the last 12 months
- Verneuil Vanina de - $218K in VIR purchases and sales in the last 12 months
- Brent Sabatini - $113K in VIR purchases and sales in the last 12 months
- Jason O'Byrne - $69K in VIR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey S. Hatfield?
Jeffrey S. Hatfield is a corporate insider, tracked as Director of Vir Biotechnology, Inc. (VIR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeffrey S. Hatfield last file a Form 4?
The only primary Form 4 on record is dated 28 May 2026.
